Cancerrisiko ved topikale immunmodulatorer
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
This article reviews if local immunosuppression of atopic dermatitis is associated with an increased risk of cancer - as implicated by a warning issued by the FDA and EMEA health authorities because systemic immunosuppression of transplanted patients leads to a significant increase of non-melanoma skin cancer and lymphoma. So far, no studies support that the use of topical immunosuppression increases the risk of local or systemic cancer.
Udgivelsesdato: 2009-Aug
Udgivelsesdato: 2009-Aug
Bidragets oversatte titel | Topical immune modulation and risk of cancer |
---|---|
Originalsprog | Dansk |
Tidsskrift | Ugeskrift for læger |
Vol/bind | 171 |
Udgave nummer | 35 |
Sider (fra-til) | 2468-71 |
Antal sider | 4 |
ISSN | 0041-5782 |
Status | Udgivet - 2009 |
ID: 20319522